| 摘要 |
The invention relates to a method of treating inflammatory conditions in a subject comprising administering to a subject a composition comprising a lymphoid thymosin-beta4 polypeptide or a functional lymphoid thymosin-beta4polypeptide variant. The invention also provides a method of promoting wound healing in a subject comprising administering to the subject a composition comprising a lymphoid thymosin-beta4 polypeptide or a functional lymphoid thymosin-beta4polypeptide variant. The invention also relates to methods of treating the above mentioned conditions in a subject comprising administering to the subject a nucleic acid encoding a lymphoid thymosin-beta4 polypeptide or a functional lymphoid thymosin-beta4 polypeptide variant. The invention also relates to pharmaceutical compositions comprising a lymphoid thymosin-beta4 polypeptide or a functional lymphoid thymosin-beta4polypeptide variant, or salt thereof, and a pharmaceutically acceptable carrier.
|
